Thermo Fisher Scientific
Biotherapeutic proteins, which include antibodies, are becoming the fastest growing category of drugs due to their efficacy for patient health. The complex nature of these large molecules brings major new challenges to the pharmaceutical scientist. The industry is undergoing a scientific revolution as it adapts to meet the challenges of characterizing biotherapeutics.
In this webinar, we discuss the difficulties of characterize monoclonal antibodies and other similar biotherapeutics and also the current technologies used to maximize glycan separation capabilities and structural elucidation.
Dr. Ken Cook EU Bio-Separations Expert, Thermo Fisher Scientific
Dr. Ken Cook has 30 years of experience supporting liquid and ion chromatography applications with Dionex and then Thermo Fisher Scientific. Dr. Cook currently supports customers with bio-separations, focusing on biotherapeutics. Previously Dr. Cook was a lecturer in biochemistry at the University of Newcastle-Upon-Tyne, UK where he focused on protein biochemistry.
* Required field
To ensure that we are complying with your preferences, we need to confirm your permission to send you communication. Please check the form of communication that you agree for us to contact you: